Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.3 EQRX 2019 Stock Option and Grant Plan
- 10.11 Eqrx, Inc. Form of Employee Confidentiality, Assignment and Non-solicitation Agreement
- 10.32 Amended and Restated Registration Rights Agreement
- 23.1 Consent of Withumsmith+brown, PC
- 23.2 Consent of Ernst & Young LLP
- 99.2 Consent of Paul Berns to Be Named As a Director
- 99.3 Consent of Alexis Borisy to Be Named As a Director
- 99.4 Consent of Jorge Conde to Be Named As a Director
- 99.5 Consent of Sandra Horning to Be Named As a Director
- 99.6 Consent of Clive Meanwell to Be Named As a Director
- 99.7 Consent of Sam Merksamer to Be Named As a Director
- 99.8 Consent of Melanie Nallicheri to Be Named As a Director
- 99.9 Consent of Krishna Yeshwant to Be Named As a Director
- 99.10 Consent of Houlihan Loukey Capital, Inc.
- Download Excel data file
- View Excel data file
Associated filings
- 2 Dec 21 EFFECT Notice of effectiveness
- 1 Dec 21 424B3 Prospectus supplement
- 30 Nov 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Nov 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Oct 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 1 Oct 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
25 Aug 21 S-4 Registration of securities issued in business combination transactions
EQRX similar filings
- 23 Nov 21 Registration of securities issued in business combination transactions (amended)
- 29 Oct 21 Registration of securities issued in business combination transactions (amended)
- 1 Oct 21 Registration of securities issued in business combination transactions (amended)
- 25 Aug 21 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 25, 2021, with respect to the consolidated financial statements of EQRx, Inc. included in the Proxy Statement of CM Life Sciences III Inc. that is made a part of the Registration Statement (Form S-4) and Prospectus of CM Life Sciences III Inc. for the registration of 415,000,000 shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
August 25, 2021